02136nas a2200253   4500000000100000008004100001260001200042653001700054653001500071653002300086653002100109653001700130653001200147100001700159700001700176700001300193700001400206245013000220856004400350300000800394490000700402520145900409022001401868       2025                            d  bMDPI AG10aRisk factors10aDisability10aNeglected Diseases10amachine learning10aEpidemiology10aleprosy1 aFreitas LRSD1 aFreitas JAOD1 aPenna GO1 aDuarte EC00aEvaluating Machine Learning Models for Predicting Late Leprosy Diagnosis by Physical Disability Grade in Brazil (2018–2022)  uhttps://www.mdpi.com/2414-6366/10/5/131  a1310 v103 a<jats:p>The severity of physical disability at leprosy diagnosis reflects the timeliness of case detection and the effectiveness of disease surveillance. This study evaluates machine learning models to predict factors associated with late leprosy diagnosis—defined as grade 2 physical disability (G2D)—in Brazil from 2018 to 2022. Using an observational cross-sectional design, we analyzed data from the Notifiable Diseases Information System and trained four machine learning models: Random Forest, LightGBM, CatBoost, XGBoost, and an Ensemble model. Model performance was assessed through accuracy, area under the receiver operating characteristic curve (AUC-ROC), recall, precision, F1 score, specificity, and Matthew’s correlation coefficient (MCC). An increasing trend in G2D prevalence was observed, averaging 11.6% over the study period and rising to 13.1% in 2022. The Ensemble model and LightGBM demonstrated the highest predictive performance, particularly in the north and northeast regions (accuracy: 0.85, AUC-ROC: 0.93, recall: 0.90, F1 score: 0.83, MCC: 0.70), with similar results in other regions. Key predictors of G2D included the number of nerves affected, clinical form, education level, and case detection mode. These findings underscore the potential of machine learning to enhance early detection strategies and reduce the burden of disability in leprosy, particularly in regions with persistent health disparities.</jats:p>  a2414-6366